Drug recalls are issued against a manufacturer and a lot number, but patients and clinicians think in terms of drug names. A patient told that mirabegron has been recalled will either stop a drug they need or ignore the news entirely, because they have no way to know whether it applies to them.
The useful question is therefore not whether the patient takes mirabegron but who made the tablets in their current bottle, and when. For a repeat prescription that information sits with the dispensing pharmacy, which can check the lot against the recall notice in minutes. Most patients will not be affected.
The general habit is worth forming, because nitrosamine recalls have now hit ranitidine, valsartan, metformin and mirabegron, and they will continue. When one lands, the message to give patients is: do not stop, take your bottle to the pharmacy, and we will substitute if it is affected. Abrupt discontinuation of a drug for a chronic condition causes certain harm to prevent an uncertain one.
- Recalls apply to manufacturers and lots, not to drug names
- The dispensing pharmacy can check a lot against the recall notice quickly
- Tell patients not to stop before checking
- Nitrosamine recalls recur — make this a standing response
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free